Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
Atherosclerosis|May 30, 2009
Prevalence and clinical features of heterozygous carriers of autosomal recessive hypercholesterolemia in SardiniaFabiana Filigheddu, Fabiana Quagliarini, Filomena Campagna, et al.Lancet (London, England)|March 19, 2002
Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysisMarcello Arca, Giovanni Zuliani, Kenneth Wilund, et al.Plos One|January 24, 2015
A functional 12T-insertion polymorphism in the ATP1A1 promoter confers decreased susceptibility to hypertension in a male Sardinian populationVictoria L Herrera, Khristine A Pasion, Ann Marie Moran, et al.Plos One|March 22, 2014
Sardinians genetic background explained by runs of homozygosity and genomic regions under positive selectionCornelia Di Gaetano, Giovanni Fiorito, Maria Francesca Ortu, et al.Science Translational Medicine|November 26, 2010
Adducin- and ouabain-related gene variants predict the antihypertensive activity of rostafuroxin, part 2: clinical studiesChiara Lanzani, Lorena Citterio, Nicola Glorioso, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|October 22, 2014
Multicentre Italian analysis on cardiovascular diseases: impact of immigrants' referral to emergency departmentVeronica Russo, Simona Santarelli, Laura Magrini, et al.Frontiers in Cardiovascular Medicine|March 7, 2022
Dissecting the Polygenic Basis of Primary Hypertension: Identification of Key Pathway-Specific ComponentsCarlo Maj, Erika Salvi, Lorena Citterio, et al.Journal of Hypertension|September 26, 2003
Genetic polymorphism of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER ProjectMaurizio Castellano, Nicola Glorioso, Daniele Cusi, et al.Plos One|September 18, 2012
An overview of the genetic structure within the Italian population from genome-wide dataCornelia Di Gaetano, Floriana Voglino, Simonetta Guarrera, et al.The Pharmacogenomics Journal|March 2, 2021
Antihypertensive treatment guided by genetics: PEARL-HT, the randomized proof-of-concept trial comparing rostafuroxin with losartanLorena Citterio, Giuseppe Bianchi, Giuseppe A Scioli, et al.Pageof 4